08:00 , Mar 2, 2009 |  BC Week In Review  |  Company News

Celerus sales and marketing update

Celerus launched 12 antibodies to be used on its Celerus Wave System for immunohistochemistry analysis. The antibodies target CD7, CD8, neutral endopeptidase (MME) (NEP) (CD10), CD30, CD34, CD79a, c-kit proto-oncogene protein (KIT,...
08:00 , Feb 12, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer ...